Wanbury Ltd
Wanbury Ltd Live Price Chart
Performance
| Previous Close | ₹ 254.65 |
| High | ₹ 262 |
| Volume | 88873 |
| 52W Range | ₹ 161.5 - ₹ 358.85 |
| Open | ₹ 255.5 |
| Low | ₹ 255 |
| Market Cap | ₹ 1161.73 Cr |
Wanbury Ltd Technicals
| 20 Day | ₹ 268.507 |
| 50 Day | ₹ 276.766 |
| 100 Day | ₹ 273.135 |
| 200 Day | ₹ 264.874 |
| 20 Day | ₹ 263.355 |
| 50 Day | ₹ 287.092 |
| 100 Day | ₹ 274.142 |
| 200 Day | ₹ 255.401 |
Wanbury Ltd Fundamentals
| ROCE | 24.186 |
| P/E Ratio | 16.100 |
| P/B Ratio | 6.230 |
| Industry P/E | 6.230 |
| Debt to Equity | 51.431 |
| ROE | 45.784 |
| EPS | 15.980 |
| Dividend Yield | 0.000 |
| Book Value | 41.318 |
| Face Value | 10.000 |
Wanbury Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 603.0075 | 578.6398 | 500.5601 | 512.6936 | 394.9215 |
| Total Expenses | 573.4568 | 547.8594 | 510.2531 | 507.9335 | 407.3272 |
| Profit After Tax | 30.5301 | 30.3994 | -10.3958 | 81.4739 | -12.6057 |
Wanbury Ltd Shareholding Pattern
| Promoter Holdings | 43.016 % |
| FIIs | 0.894 % |
| DIIs | 0.059 % |
| MutualFund | 0.003 % |
| Retail | 41.909 % |
| Others - | 14.119 % |
About Wanbury Ltd
Wanbury Limited, formerly known Pearl Organics Limited was incorporated in August, 1988. The Company attained its present name in September 2004. The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Hon'ble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/- each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively. The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE i ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 44.01 +0.88 (+2.04%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 514.25 -2.8 (-0.54%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 7,106.50 -29.5 (-0.41%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 588.10 +28 (+5%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,175.00 -175 (-0.66%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,423.50 +3.5 (+0.25%) |
FAQs on Wanbury Ltd
1. Can I buy Wanbury Ltd from PL Capital? ›
2. Does Wanbury Ltd pay dividends? ›
3. What is the current share price of Wanbury Ltd ? ›
4. What is the 52-week high and low of Wanbury Ltd ? ›
Start SIP in Wanbury Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
